BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1697012)

  • 1. Long-term effects of 2'-deoxycoformycin treatment on cytokine production in patients with hairy cell leukemia.
    Ho AD; Männel DN; Wulf G; Kirchner H; Gundt A; Trede I; Rensch K; Hunstein W
    Leukemia; 1990 Aug; 4(8):584-9. PubMed ID: 1697012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.
    Urba WJ; Baseler MW; Kopp WC; Steis RG; Clark JW; Smith JW; Coggin DL; Longo DL
    Blood; 1989 Jan; 73(1):38-46. PubMed ID: 2783373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
    Seymour JF; Talpaz M; Kurzrock R
    Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose metabolism of hairy cells.
    Kraut EH; Husney RM; Sagone AL
    Leukemia; 1992 Aug; 6(8):834-8. PubMed ID: 1640737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T lymphocyte activation by pokeweed mitogen induces production of TNF-alpha and GM-CSF and helper signaling by IL-1 and IL-6 results in IL-2-dependent T cell growth.
    Wallays G; Ceuppens JL
    Eur Cytokine Netw; 1993; 4(4):269-77. PubMed ID: 8268417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
    Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
    Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormally activated T lymphocytes in the spleen of patients with hairy-cell leukemia.
    Kluin-Nelemans JC; Kester MG; Oving I; Cluitmans FH; Willemze R; Falkenburg JH
    Leukemia; 1994 Dec; 8(12):2095-101. PubMed ID: 7807997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
    Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
    Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequate production of hematopoietic growth factors in hairy cell leukemia: up-regulation of interleukin 6 by recombinant IFN-alpha in vitro.
    Schwarzmeier JD; Hilgarth M; Nguyen ST; Shehata M; Gruber G; Spittler A; Willheim M; Boltz-Nitulescu G; Höcker P; Berger R
    Cancer Res; 1996 Oct; 56(20):4679-85. PubMed ID: 8840984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass.
    Naldini A; Borrelli E; Cesari S; Giomarelli P; Toscano M
    Cytokine; 1995 Feb; 7(2):165-70. PubMed ID: 7780036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha interferon production in patients with hairy cell leukemia: correlations with disease activity and remission status.
    Lepe-Zuniga JL; Quesada JR; Baron S; Reuben J; Gutterman JU
    Hematol Pathol; 1987; 1(3):157-65. PubMed ID: 3150846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway.
    Lorré K; Fransen L; Ceuppens JL
    Eur Cytokine Netw; 1992; 3(3):321-30. PubMed ID: 1353987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM; Vilcek J
    J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
    Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive effects of pentostatin.
    Kraut EH; Neff JC; Bouroncle BA; Gochnour D; Grever MR
    J Clin Oncol; 1990 May; 8(5):848-55. PubMed ID: 2332771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hairy cell leukemia with deoxycoformycin (YK-176). The Deoxycoformycin (YK-176) Study Group.
    Shimoyama M; Tobinai K; Yamaguchi K; Hirashima K; Itoh S; Konishi H; Mikuni C; Togawa A; Hotta T; Toyoda N
    Jpn J Clin Oncol; 1992 Dec; 22(6):406-10. PubMed ID: 1291757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and TNF-alpha in human peripheral blood.
    Hagiwara E; Abbasi F; Mor G; Ishigatsubo Y; Klinman DM
    Cytokine; 1995 Nov; 7(8):815-22. PubMed ID: 8664449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokines in children with immunodeficiencies].
    Kowalczyk D
    Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.